JP5833289B2 - Chemical solution applicator and chemical solution application kit - Google Patents

Chemical solution applicator and chemical solution application kit Download PDF

Info

Publication number
JP5833289B2
JP5833289B2 JP2010018074A JP2010018074A JP5833289B2 JP 5833289 B2 JP5833289 B2 JP 5833289B2 JP 2010018074 A JP2010018074 A JP 2010018074A JP 2010018074 A JP2010018074 A JP 2010018074A JP 5833289 B2 JP5833289 B2 JP 5833289B2
Authority
JP
Japan
Prior art keywords
chemical solution
chemical
sponge
shaft
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2010018074A
Other languages
Japanese (ja)
Other versions
JP2011156024A (en
Inventor
中村 裕之
裕之 中村
英昭 小水流
英昭 小水流
直孝 上廣
直孝 上廣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Fine Chemicals Co Ltd
Original Assignee
Toray Fine Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Fine Chemicals Co Ltd filed Critical Toray Fine Chemicals Co Ltd
Priority to JP2010018074A priority Critical patent/JP5833289B2/en
Publication of JP2011156024A publication Critical patent/JP2011156024A/en
Application granted granted Critical
Publication of JP5833289B2 publication Critical patent/JP5833289B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Packages (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Description

本発明は、消毒薬などの薬液を患部に塗布するのに用いる薬液塗布具、及び薬液塗布用キット、すなわち開封すれば即座に薬液を患部に塗布することができるように薬液塗布具を容器内に収容してなる薬液塗布用キットに関する。   The present invention relates to a chemical solution applicator used for applying a chemical solution such as a disinfectant to an affected part, and a chemical solution application kit, i.e., the chemical solution applicator is placed in a container so that the chemical solution can be immediately applied to the affected part when opened It is related with the chemical | medical solution application kit accommodated in.

患部に消毒薬などの薬液を塗布する場合、綿棒や綿球などに薬液を含浸させて塗布するのが一般的である。しかし、患部に薬液を塗布するたびに薬液を別途用意して含浸させることは面倒であるため、予め薬液を含浸させた綿球や綿棒などを容器に封入して薬液塗布用キットして提供することが提案されている。   When applying a chemical solution such as a disinfectant to the affected area, it is common to apply a chemical solution to a cotton swab or cotton ball. However, since it is cumbersome to prepare and impregnate the chemical solution separately every time the chemical solution is applied to the affected part, a cotton ball or a cotton swab impregnated with the chemical solution is enclosed in a container and provided as a chemical solution application kit. It has been proposed.

例えば特許文献1には、薬液を含浸させた複数の綿球を、容器に複数形成された収容凹部にそれぞれ挿入し、各収容凹部の開口部をシール部材によって密封してなる構成の薬液塗布用キットが開示されている。   For example, in Patent Document 1, a plurality of cotton balls impregnated with a chemical solution are respectively inserted into storage recesses formed in a container, and the opening of each storage recess is sealed with a seal member. A kit is disclosed.

特許文献2には、軸体の端部に塗布液含浸部を設けた塗布液含浸綿棒と、前記塗布液含浸部を収容する凹部、および、この凹部から連続し塗布液含浸部に隣接する軸体を収容する溝部が形成されたカップ部材と、このカップ部材の開口面上に配置して凹部内を密閉する被覆フィルムとを備えた薬液塗布用キットが開示されている。   Patent Document 2 discloses a coating liquid-impregnated cotton swab provided with a coating liquid-impregnated portion at the end of a shaft body, a concave portion that accommodates the coating liquid-impregnated portion, and a shaft that is continuous from the concave portion and adjacent to the coating liquid-impregnated portion. There is disclosed a chemical solution coating kit including a cup member in which a groove portion for accommodating a body is formed and a covering film that is disposed on the opening surface of the cup member and seals the inside of the recess.

実開昭62−172449号公報の請求項1及び図1Claim 1 and FIG. 1 of Japanese Utility Model Laid-Open No. 62-172449. 特開2007−319535号公報の請求項1及び図1Claim 1 and FIG. 1 of Japanese Patent Laid-Open No. 2007-319535

従来使用されていた薬液塗布具は、薬液を吸収した後薬液を放液する量(以下「放液量」ともいう)が十分でないため、含浸した薬液量に対して十分な薬液を塗布することが難しいという課題を抱えていた。この課題を解決するために、多くの薬液を塗布具と共に容器内に収容すると、塗布具の薬液を吸収し保持し得る量(以下「抱液可能量」ともいう)が十分ではないため、容器内で薬液がダブつき、綿棒を摘み上げた際に薬液が滴り落ちたり、多くの薬液が使用後に残って無駄を生じたり、薬液により軸が汚れてしまったり、蓋体をシールする時にシール部分に薬液が付着して密閉性を妨げたりするなどの問題を生じることになる。   The chemical solution applicator that has been used in the past is not sufficient to release the chemical solution after absorbing the chemical solution (hereinafter also referred to as “liquid release amount”), so apply sufficient chemical solution to the impregnated chemical solution amount. However, it was difficult. In order to solve this problem, if a large amount of chemical solution is accommodated in the container together with the applicator, the amount of the chemical that can be absorbed and retained by the applicator (hereinafter also referred to as “amount of liquid embracing”) is not sufficient. When the swab is picked up, the medicinal solution dripping down, a lot of medicinal solution remains after use, causing waste, the shaft gets dirty with the medicinal solution, or the seal part is sealed This causes problems such as the chemical solution adhering to the surface and hindering sealing.

そこで本発明者は、厚さ方向にのみ圧縮成型してなるセルローススポンジから薬液塗布部を形成し、この薬液塗布部に樹脂製の軸部を固着させて薬液塗布具を提供することを発案した。厚さ方向にのみ圧縮成型してなるセルローススポンジから薬液塗布部を形成することによって、該薬液塗布部の薬液抱液量・放液量を高め、必要最低限の薬液を薬液塗布部に含浸させるようにして、患部に薬液を容易に塗布することができ、しかも、使用する際に、薬液が滴り落ちたり、使用後に余分な薬液が過剰に残ったり、薬液により軸が汚れてしまったり、製造時にシール部分に薬液が付着して密閉性を妨げることがない。   Therefore, the inventor of the present invention has proposed that a chemical application part is provided by forming a chemical application part from a cellulose sponge formed by compression molding only in the thickness direction, and fixing a resin shaft to the chemical application part. . By forming the chemical solution application part from cellulose sponge formed by compression molding only in the thickness direction, the chemical solution application amount of the chemical solution application part is increased and the liquid discharge amount is increased, and the minimum required chemical solution is impregnated in the chemical application part. In this way, the chemical solution can be easily applied to the affected area, and when used, the chemical solution drippings, excessive excess chemical solution remains after use, the shaft gets dirty due to the chemical solution, manufacturing Occasionally a chemical solution adheres to the seal portion and does not disturb the sealing performance.

ところが、セルローススポンジからなる薬液塗布部に樹脂製の軸部を、接着剤を用いて固着させると接着破壊が生じる一方、接着剤を用いず固着させると薬液抱液量が低下すると言った新たな課題が新たに判明した。
また、厚さ方向にのみ圧縮成形されたスポンジは、それだけであれば復元力を発揮し、薬液を吸収しつつ厚さ方向に膨らんで十分な量の薬液を抱液する(すなわち、吸収して保持する)ことができるが、樹脂製の軸部を固着させると、樹脂がスポンジ内に入り込み復元力が低下して薬液抱液量が低下することが新たに判明した。
However, when the resin shaft part is fixed to the chemical solution application part made of cellulose sponge using an adhesive, the adhesive breakage occurs. On the other hand, if the adhesive is not used, the amount of the chemical solution is reduced. A new issue has been identified.
In addition, a sponge that is compression-molded only in the thickness direction exhibits a restoring force if it is alone, and swells in the thickness direction and absorbs a sufficient amount of drug solution while absorbing the drug solution (that is, absorbs the drug solution). However, it has been newly found that when the resin shaft is fixed, the resin enters the sponge and the restoring force is reduced, so that the amount of the liquid solution is reduced.

そこで本発明は、セルローススポンジに軸部を固着する場合に、接着破壊を生じさせず、且つ薬液抱液量を低下させることなく固着することができ、さらに好ましくは厚さ方向のみに圧縮成形されたスポンジの復元力が低下する原因を究明し、十分な量の薬液を抱液する(すなわち、吸収して保持する)ことができ、効率よく薬液を放液することができる新たな薬液塗布具を提供せんとするものである。   Therefore, the present invention can fix the shaft portion to the cellulose sponge without causing adhesive breakage and without reducing the amount of the chemical solution, and more preferably compression molding only in the thickness direction. A new chemical applicator that investigates the cause of the reduction of the restoring force of the sponge and can hold (ie, absorb and hold) a sufficient amount of the chemical and efficiently release the chemical Is intended to provide.

かかる目的のため、本発明は、セルローススポンジからなる薬液塗布部と、薬液塗布部に固着してなる樹脂製の軸部とを備えた薬液塗布具であって、当該軸部を構成する樹脂の一部が、薬液塗布部を構成するスポンジの内部空隙に侵入して係合することにより、薬液塗布部と軸部は固着してなる構成を備えた薬液塗布具を提案する。   For this purpose, the present invention provides a chemical solution applicator provided with a chemical solution application portion made of cellulose sponge and a resin shaft portion fixed to the chemical solution application portion, wherein the resin constituting the shaft portion is made of Proposed is a chemical applicator having a structure in which a part of the chemical application part and the shaft part are fixed by partly entering and engaging with the internal gap of the sponge constituting the chemical application part.

軸部を構成する樹脂を溶融させるなどして、軸部を構成する樹脂の一部をスポンジの内部空隙、すなわちスポンジの空隙孔内に侵入させて冷却固化させて物理的に係合させることにより、接着破壊などを生じることなく、薬液塗布部と軸部を固着することができる。   By melting the resin that constitutes the shaft part, etc., by allowing a part of the resin that constitutes the shaft part to enter the internal gap of the sponge, that is, the gap hole of the sponge, and solidify by cooling and physically engaging The chemical solution application portion and the shaft portion can be fixed without causing adhesive breakage or the like.

また、厚さ方向のみに圧縮成形されたスポンジの復元力が低下する原因を究明した結果、薬液塗布部の上面全体に固着させた場合に復元力が低下することが分かった。そこで、厚さ方向にのみ圧縮成形されたセルローススポンジから薬液塗布具を形成する場合には、軸部の基端部を、薬液塗布部の上面の2〜90%の面積部分に固着することにより、薬液塗布部の抱液力を保持しつつ、薬液塗布部に軸部をしっかりと固着することができるようになった。   Further, as a result of investigating the cause of the reduction of the restoring force of the sponge compression-molded only in the thickness direction, it was found that the restoring force is lowered when the sponge is fixed to the entire upper surface of the chemical solution application portion. Therefore, in the case of forming a chemical solution applicator from a cellulose sponge compression-molded only in the thickness direction, the base end portion of the shaft portion is fixed to an area portion of 2 to 90% of the upper surface of the chemical solution application portion. The shaft part can be firmly fixed to the chemical solution application part while maintaining the liquid holding power of the chemical solution application part.

本発明はまた、上記の薬液塗布具と、
前記薬液塗布部を収容する薬液塗布部収容凹部、及びこの薬液塗布部収容凹部と連通した、軸部を収容する軸部収容凹部を有する収容容器と、
薬液塗布部収容凹部及び軸部収容凹部を被覆し得るシート蓋体と、を備えた薬液塗布用キットであって、
薬液塗布部収容凹部内に、薬液塗布部と共に当該薬液塗布部の抱液可能量の15〜95質量%量の薬液を収容し、軸部収容凹部内に軸部を収容し、前記薬液塗布部収容凹部及び軸部収容凹部をシート蓋体で密閉してなる構成を備えた薬液塗布用キットを提案する。
The present invention also includes the above-described chemical solution applicator,
A container containing a chemical liquid application part accommodating recess for accommodating the chemical liquid application part, and a shaft part accommodating concave part communicating with the chemical liquid application part accommodating concave part for accommodating a shaft part;
A chemical liquid application kit comprising: a sheet lid that can cover the chemical liquid application portion accommodating recess and the shaft portion accommodating recess;
In the chemical liquid application part housing recess, together with the chemical liquid application part, 15 to 95% by mass of the liquid storable amount of the chemical liquid application part is accommodated, the shaft part is accommodated in the shaft part accommodating recess, and the chemical liquid application part A chemical solution coating kit having a configuration in which a housing recess and a shaft housing recess are sealed with a sheet lid is proposed.

このように、薬液塗布部に吸収保持させる薬液量を、抱液可能量の15〜95質量%量としても、患部に必要十分な量の薬液を塗布することができるばかりか、余分な薬液が薬液塗布部収容凹部内に存在しないから、患部に薬液を塗布する際に薬液が滴り落ちたり、使用後に余分な薬液が過剰に残ったり、薬液により軸が汚れてしまったり、製造時にシール部分に薬液が付着して密閉性を妨げることがない。   Thus, even if the amount of the chemical solution to be absorbed and held in the chemical solution application part is 15 to 95% by mass of the solvable amount, not only can a sufficient amount of the chemical solution be applied to the affected part, Since it does not exist in the recess where the drug solution is applied, the drug solution may drip when applied to the affected area, excessive drug solution may remain after use, the shaft may become dirty due to the solution, and the seal part may become dirty during manufacturing. The chemical solution does not adhere and does not hinder sealing.

本発明の薬液塗布具及びその容器の一実施形態の一例を示した斜視図である。It is the perspective view which showed an example of one Embodiment of the chemical | medical solution applicator of this invention, and its container. 本発明の薬液塗布具の使用状態の一例を示した斜視図である。It is the perspective view which showed an example of the use condition of the chemical | medical solution applicator of this invention. 固着試験で使用した薬液塗布具の軸部を示した平面図である。It is the top view which showed the axial part of the chemical | medical solution applicator used by the adhesion test. 固着試験で使用した薬液塗布具の軸部と薬液塗布部を示した平面図である。It is the top view which showed the axial part and chemical | medical solution application part of the chemical | medical solution applicator used by the adhesion test.

以下、本発明の好適な実施形態について説明する。但し、本発明が下記に説明する実施形態に限定されるものではない。   Hereinafter, preferred embodiments of the present invention will be described. However, the present invention is not limited to the embodiments described below.

本発明の一実施形態に係る薬液塗布用キット(以下「本薬液塗布用キット」という)は、図1及び図2に示すように、スポンジからなる薬液塗布部2、及び軸部3を有する薬液塗布具1と、前記薬液塗布部2を収容する薬液塗布部収容凹部5、及び軸部3を収容する軸部収容凹部4aを有する収容容器4と、薬液塗布部収容凹部5内に収容する薬液と、薬液塗布部収容凹部5及び軸部収容凹部4aを被覆し得るシート蓋体(図示せず)と、を備えたものである。   A chemical solution application kit according to an embodiment of the present invention (hereinafter referred to as a “main drug solution application kit”) includes a chemical solution application part 2 made of a sponge and a shaft part 3 as shown in FIGS. An applicator 1, a container 4 having a chemical liquid application part accommodating recess 5 for accommodating the chemical liquid application part 2, a shaft part accommodating recess 4 a for accommodating the shaft part 3, and a chemical liquid accommodated in the chemical liquid application part accommodating recess 5 And a sheet lid (not shown) capable of covering the chemical solution application portion receiving recess 5 and the shaft portion receiving recess 4a.

(薬液塗布部2)
薬液塗布部2の形状は任意であるが、製造工程の簡略化と、薬液を塗布し易いという観点とから、扁平な板状であるのが好ましい。上面視した際の形状は、円状、楕円状、四角状、多角形状などの任意である。
(Chemical solution application part 2)
The shape of the chemical solution application unit 2 is arbitrary, but is preferably a flat plate from the viewpoint of simplifying the manufacturing process and easy application of the chemical solution. The shape when viewed from above is arbitrary, such as a circle, an ellipse, a square, or a polygon.

薬液塗布部2は、OH基を有するセルロースを主成分とするスポンジから形成するのが好ましい。
親水基であるOH基を有するセルロースを主成分とするスポンジから薬液塗布部2を形成すれば、薬液、特に水溶液からなる薬液(例えばポビドンヨード液)となじみ易く、薬液を吸収し保持し得る量、すなわち抱液可能量を高めることができる。しかも、薬液を含んだウェット状態になると表面が柔らかくなり、柔らかい感触で塗布することができる。
The chemical solution application part 2 is preferably formed from a sponge mainly composed of cellulose having an OH group.
If the chemical solution application part 2 is formed from a sponge mainly composed of cellulose having an OH group that is a hydrophilic group, the chemical solution, in particular, a chemical solution consisting of an aqueous solution (for example, povidone iodine solution) is easily compatible with and can absorb and retain the chemical solution, That is, it is possible to increase the amount of liquid that can be held. Moreover, when the wet state containing the chemical solution is reached, the surface becomes soft and can be applied with a soft feel.

この際、前記スポンジは、例えば強度を高めるために、母材繊維であるセルロースに補強繊維を含んでいてもよい。補強繊維としては、綿(コットン)や亜麻、ラミー、パルプ等を単独またはそれらを組合せて使用することができる。
例えば、セルロース100重量部に対して補強繊維、例えば綿繊維を20〜50重量部含有するものが好ましく、特に20〜40重量部含有するものが好ましい。補強繊維を20〜50重量部含有させることによって、引張強度や保形性を高めることができ、多くの薬液を含んでいてもスポンジの形状を保つことができ、患部に薬液を塗布し易くなる。
At this time, the sponge may contain reinforcing fibers in cellulose, which is a base material fiber, for example, in order to increase strength. As the reinforcing fiber, cotton (cotton), flax, ramie, pulp and the like can be used alone or in combination.
For example, those containing 20 to 50 parts by weight of reinforcing fibers, such as cotton fibers, with respect to 100 parts by weight of cellulose are preferred, and those containing 20 to 40 parts by weight are particularly preferred. By containing 20 to 50 parts by weight of the reinforcing fiber, the tensile strength and shape retention can be increased, the shape of the sponge can be maintained even if a lot of chemicals are contained, and the chemical solution can be easily applied to the affected part. .

薬液塗布部2のスポンジの空隙率は95〜99%であるのが好ましい。スポンジの空隙率が95〜99%であれば、薬液を吸収し保持する量、すなわち抱液可能量を高めることができ、しかも、吸収保持した薬液を容易に放出するから、薬液を容易に塗布することができる。
空隙率は、下記式(1)で算出される値である。
(1)・・空隙率=(真密度−見掛密度)×100/真密度
なお、見掛密度とは、スポンジの見掛体積(空隙含)に対する重量の割合であり、真密度とは、スポンジの見掛体積から空隙の容積を差し引いたスポンジ構成材料の実質体積に対する重量の割合である。
The porosity of the sponge of the chemical solution application part 2 is preferably 95 to 99%. If the porosity of the sponge is 95 to 99%, it is possible to increase the amount of liquid that is absorbed and retained, that is, the amount of liquid that can be held, and the liquid that has been absorbed and retained is easily released. can do.
The porosity is a value calculated by the following formula (1).
(1) Void ratio = (true density−apparent density) × 100 / true density Note that the apparent density is the ratio of the weight to the apparent volume (including voids) of the sponge. It is the ratio of the weight to the real volume of the sponge constituent material obtained by subtracting the void volume from the apparent volume of the sponge.

薬液塗布部2のスポンジの空隙は、外部に連通した空隙であるのが好ましい。後述するように、添加した芒硝結晶を溶出させる方法で空隙を形成する場合には、空隙は外部に連通した空隙となる。   The gap of the sponge of the chemical solution application part 2 is preferably a gap communicating with the outside. As will be described later, when the void is formed by the method of eluting the added mirabilite crystal, the void is a void communicating with the outside.

薬液塗布部2のスポンジの空隙の平均径は、0.1mm〜3.3mmであるのが好ましく、特に0.5mm〜2.0mm、中でも特に0.7mm〜0.9mmであるのが好ましい。
スポンジの空隙率の平均径が3.3mm以下、特に2.0mm以下であれば、薬液を吸収し保持する量、すなわち抱液可能量を高めることができる。
なお、空隙の平均径は、電子顕微鏡で観察して求めることもできるが、後述するように、添加した芒硝結晶を溶出させることにより空隙を形成する製造方法においては、芒硝結晶の粒径と空隙の平均径は略一致するから、芒硝結晶の平均径に読み替えることができる。
The average diameter of the gap in the sponge of the chemical solution application part 2 is preferably 0.1 mm to 3.3 mm, particularly preferably 0.5 mm to 2.0 mm, and particularly preferably 0.7 mm to 0.9 mm.
If the average diameter of the porosity of the sponge is 3.3 mm or less, particularly 2.0 mm or less, it is possible to increase the amount that absorbs and retains the chemical solution, that is, the amount that can be held.
The average diameter of the voids can be obtained by observing with an electron microscope. However, in the production method for forming voids by eluting the added mirabilite crystals, as described later, the particle size and voids of the mirabilite crystals are used. Since the average diameters of these are substantially the same, it can be read as the average diameter of the mirabilite crystals.

薬液塗布部2を構成するスポンジの、単位体積当たりの薬液(例えば10w/v%ポビドンヨード液(比重約1.03))の抱液可能量は、該スポンジの体積と同量であるのが好ましい。具体的には、0.95〜1.10g/cm3、特に0.98〜1.10g/cm3であるのが好ましい。
単位体積当たりの抱液可能量が0.95〜1.10g/cm3であれば、患部に塗布するのに十分な量の薬液を比較的小さな体積のスポンジで吸収保持できるから、薬液塗布部2及び薬液塗布部収容凹部5を小さくすることができ、しかも薬液塗布部収容凹部5内に余分な薬液を収容する必要を無くすことができる。
It is preferable that the amount of the liquid (for example, 10 w / v% povidone iodine liquid (specific gravity about 1.03)) that can be hydrated in the sponge constituting the chemical liquid application unit 2 is the same as the volume of the sponge. . Specifically, it is preferably 0.95 to 1.10 g / cm 3 , particularly preferably 0.98 to 1.10 g / cm 3 .
If the amount of lysable per unit volume is 0.95 to 1.10 g / cm 3 , a sufficient amount of drug solution to be applied to the affected area can be absorbed and held by a relatively small volume of sponge. 2 and the chemical solution application part accommodating recess 5 can be made small, and the need to store extra chemical in the chemical solution application part accommodating recess 5 can be eliminated.

単位体積当たりの抱液可能量は、式(2)で算出される値である。
(2)・・単位体積当たりの抱液可能量=吸液時の単位体積重量−乾燥時の単位体積重量
この際、吸液時の単位体積重量は、検体(スポンジの直方体)全体を10w/v%ポビドンヨード液に浸し、5分間浸漬させた後、金属メッシュ上に置いて検体から液滴を取り除いた上で測定する単位体積重量である。
なお、抱液とは、スポンジが液を吸収保持することの意である。
The possible amount of liquid hydrate per unit volume is a value calculated by equation (2).
(2) ··· Amount of liquid held per unit volume = unit volume weight at the time of liquid absorption-unit volume weight at the time of drying At this time, the unit volume weight at the time of liquid absorption is 10 w / w for the entire specimen (a sponge cuboid) It is a unit volume weight measured after soaking in a v% povidone iodine solution and soaking for 5 minutes and then placing on a metal mesh to remove droplets from the specimen.
In addition, the liquid holding means that the sponge absorbs and holds the liquid.

薬液塗布部2は、薬液、特に10w/v%ポビドンヨード液の吸液速度が0.03〜0.5s/g、特に0.04〜0.5s/gであるスポンジを使用するのが好ましい。
吸液速度が0.03〜0.5s/gであるスポンジであれば、収容容器4に薬液塗布具1を挿入した後、薬液塗布部収容凹部5内の薬液塗布部2に薬液を供給する場合に、薬液塗布部2が極めて短時間のうちに薬液を吸収するため、薬液塗布部2に薬液を供給してからシート蓋体をシールするまでの工程を一連の生産ライン上で実施することができ、本薬液塗布用キットの製造をオンラインで行うことができる。また、薬液塗布部2に薬液を注いだ際に瞬時に吸収できるから、薬液がシール部分に跳ねることがなく、シール性をより確実に確保することができる。
It is preferable to use a sponge having a liquid absorption rate of 0.03 to 0.5 s / g, particularly 0.04 to 0.5 s / g for the chemical solution, particularly 10 w / v% povidone iodine solution.
If the sponge has a liquid absorption speed of 0.03 to 0.5 s / g, the chemical liquid applicator 1 is inserted into the container 4 and then the chemical liquid is supplied to the chemical liquid application section 2 in the chemical liquid application section receiving recess 5. In this case, since the chemical solution application unit 2 absorbs the chemical solution within an extremely short time, the steps from supplying the chemical solution to the chemical solution application unit 2 to sealing the sheet lid are performed on a series of production lines. The medicinal solution application kit can be manufactured online. Moreover, since it can absorb instantly when a chemical | medical solution is poured into the chemical | medical solution application part 2, a chemical | medical solution does not jump to a seal | sticker part, but can ensure sealing performance more reliably.

薬液の吸液速度は、ステンレス製パッド内に10w/v%ポビドンヨード液を注ぎ、次いで検体(スポンジの直方体)をステンレス製パッド内に置いて下部をポビドンヨード液に浸し、検体(スポンジ)をステンレス製パッド内に置いてから検体の上面部まで吸液するまでの時間を測定し、次の式(4)より算出することができる。
(4)・・吸液速度=測定値(sec)/検体の吸液前の重量(g)
The liquid absorption speed of the chemical solution is as follows: 10% w / v povidone iodine solution is poured into a stainless steel pad, then the specimen (sponge cuboid) is placed in the stainless steel pad and the lower part is immersed in the povidone iodine liquid, and the specimen (sponge) is made of stainless steel. It can be calculated from the following equation (4) by measuring the time from when it is placed in the pad until the top surface of the specimen is sucked.
(4) .. Liquid absorption speed = measured value (sec) / weight of sample before liquid absorption (g)

薬液塗布部2は、圧縮前に比べて厚さが1/4〜1/10となるように厚さ方向にのみ圧縮成形されたスポンジ、言い換えれば、薬液を吸収すると圧縮された分だけ厚さ方向に膨張して復元するスポンジであるのが好ましい。
圧縮前に比べて厚さが1/4以下となるように厚さ方向にのみ圧縮成形されたスポンジを使用することにより、形態が安定するため、インサート成形時スポンジを金型に挿入しやすかったり、吸液速度を上記の如く高めることができると共に、薬液を吸収した際に厚さ方向に復元膨張し、しかも吸収後の形状が安定するから、薬液塗布部収容凹部5の平面視形状を、薬液塗布部2の平面視形状に沿って若干大きく形成すればよく、しかも安定した状態に薬液塗布部2を収容したりすることができる。なお、圧縮前に比べて厚さが1/10未満となるように厚さ方向にのみ圧縮することは、現在の成形技術上困難である。
かかる観点から、薬液塗布部2は、圧縮前に比べて厚さが1/4〜1/10、中でも1/5〜1/10となるように厚さ方向にのみ圧縮成形されたスポンジであるのがより一層好ましい。
The chemical solution application part 2 is a sponge that is compression-molded only in the thickness direction so that the thickness is ¼ to 1/10 of that before compression, in other words, the thickness corresponding to the compressed amount when absorbing the chemical solution. A sponge that expands and restores in the direction is preferred.
By using a sponge that is compression-molded only in the thickness direction so that the thickness is 1/4 or less compared to before compression, the form is stable, so it is easy to insert the sponge into the mold during insert molding. The liquid absorption speed can be increased as described above, and when the chemical liquid is absorbed, it is restored and expanded in the thickness direction, and the shape after absorption is stabilized. What is necessary is just to form a little large along the planar view shape of the chemical | medical solution application part 2, and also the chemical | medical solution application part 2 can be accommodated in the stable state. In addition, it is difficult in the present molding technique to compress only in the thickness direction so that the thickness is less than 1/10 compared to before compression.
From this point of view, the chemical solution application part 2 is a sponge that is compression-molded only in the thickness direction so that the thickness is 1/4 to 1/10, especially 1/5 to 1/10, compared to before compression. Is even more preferable.

(スポンジの製造方法)
上記のようなスポンジの製造方法は特に限定するものではない。好ましい一例としては、木材等からのチップを溶解して繊維素とし、これを水酸化ナトリウム等のアルカリで処理してから二硫化炭素等を添加してビスコースをつくる。このビスコースに硫酸ナトリウム(芒硝)からなる微小芒硝結晶を混合し、シート状あるいはブロック状に成型し、煮沸及び酸凝固させて微小芒硝結晶を溶出させて多孔質化させ、水洗、乾燥、さらには厚み方向に加圧して圧縮させることによって得ることができる。
(Sponge production method)
The method for producing the sponge as described above is not particularly limited. As a preferred example, chips from wood or the like are dissolved to form fiber, which is treated with an alkali such as sodium hydroxide, and then carbon disulfide or the like is added to make viscose. This viscose is mixed with fine sodium sulfate crystal made of sodium sulfate (sodium salt), molded into a sheet or block, boiled and acid coagulated to elute the fine salt crystal, make it porous, washed with water, dried, Can be obtained by pressing in the thickness direction and compressing.

より具体的な一例としては、木材パルプを水酸化ナトリウム溶液に浸漬し、圧搾後に粉砕してアルカリセルロース(クラム)とし、その後17℃で10時間老成後、二硫化炭素を加えセルロースザンテートを得、このセルロースザンテートに繊維長0.1〜5mmの未老成のクラムと水酸化ナトリウム、水を加えて溶解し、ビスコースを得る。
得られたビスコースと平均粒径0.1mm〜3.3mmの微小芒硝結晶とを混合機の中で16〜20℃に保ちながら混合する。この混合物を金型に押出機を介して加圧充填する。その際、押出機周辺の温度も16〜20℃になるように温度調節する。混合物が充填された金型を約90℃の芒硝浴の中で約8時間煮沸し、凝固させて前記微小芒硝結晶を溶出させて多孔質化させ、そして得られた成形体を水洗、乾燥、さらには厚み方向に加圧して圧縮させることによって得ることができる。
但し、かかる方法において、各温度や時間等は調整可能である。
As a more specific example, wood pulp is immersed in a sodium hydroxide solution, pulverized after pressing into alkali cellulose (crumb), then aged at 17 ° C. for 10 hours, and then carbon disulfide is added to obtain cellulose xanthate. The cellulose xanthate is dissolved by adding unaged crumb having a fiber length of 0.1 to 5 mm, sodium hydroxide, and water to obtain viscose.
The obtained viscose and fine sodium silicate crystals having an average particle size of 0.1 mm to 3.3 mm are mixed while being kept at 16 to 20 ° C. in a mixer. This mixture is pressurized and filled into a mold through an extruder. At that time, the temperature around the extruder is adjusted to 16 to 20 ° C. The mold filled with the mixture is boiled for about 8 hours in a mirabilite bath at about 90 ° C., solidified to elute the fine mirabilite crystals, and the resulting compact is washed with water, dried, Furthermore, it can be obtained by pressurizing and compressing in the thickness direction.
However, in this method, each temperature, time, etc. can be adjusted.

なお、スポンジを厚さ方向にのみ圧縮成形する方法としては、例えばスポンジをインサート成形して軸部を固着する場合に、インサートした際にスポンジを圧縮して成形することもできる。   As a method of compression-molding the sponge only in the thickness direction, for example, when the sponge is insert-molded and the shaft portion is fixed, the sponge can be compressed and molded when inserted.

この際、芒硝結晶の平均粒径を変化させることにより、スポンジ内の空隙の大きさを調整することができ、平均粒径の小さな芒硝結晶を使用することによってスポンジの空隙を小さくすることができる。よって、芒硝結晶の平均粒径は0.5mm〜2.0mmであるのが特に好ましく、中でも特に0.7mm〜0.9mmであるのがさらに好ましい。   At this time, the size of the voids in the sponge can be adjusted by changing the average particle size of the mirabilite crystal, and the voids in the sponge can be reduced by using the mirabilite crystal having a small average particle size. . Therefore, the average particle size of the mirabilite crystal is particularly preferably 0.5 mm to 2.0 mm, and more preferably 0.7 mm to 0.9 mm.

厚み方向に圧縮成型して製造されたスポンジは、薬液を保持し得る量(抱液可能量)が多いばかりか、吸液速度が速く、しかも薬液を吸収すると所定の厚み(例えば9割前後)に正確に回復するため、薬液の供給量とスポンジの体積に応じて薬液塗布部収容凹部5の大きさを正確に設計することができる。   Sponges produced by compression molding in the thickness direction not only have a large amount of liquid that can hold medicinal solution (capable of lysing), but also have a high liquid absorption rate and a predetermined thickness (for example, around 90%) when the medicinal solution is absorbed. Therefore, the size of the chemical solution application portion receiving recess 5 can be accurately designed according to the supply amount of the chemical solution and the volume of the sponge.

薬液塗布部2の形状は特に限定するものではないが、できるだけ少ない量の薬液を効率良く広範囲に塗布できるように、図1に示すように、扁平な板状体とするのが好ましい。   Although the shape of the chemical solution application part 2 is not particularly limited, it is preferably a flat plate-like body as shown in FIG. 1 so that a small amount of chemical solution can be efficiently and widely applied.

(軸部3)
薬液塗布具1の軸部3は、樹脂製であれば、その材質は特に限定するものではないが、成形性及び価格を考慮すると、ポリプロピレン、ポリエチレン、ポリスチレンなどが好ましい。
(Shaft 3)
The material of the shaft portion 3 of the chemical solution applicator 1 is not particularly limited as long as it is made of resin, but polypropylene, polyethylene, polystyrene, and the like are preferable in consideration of moldability and price.

軸部3は、棒状の掴み部3aの基端部に薄板状の固着片部3bを備えていればよい。
固着片部3bの形状は、特に限定するものではないが、平面視した際に円状、半円状、楕円状であるのが好ましい。中でも、半円状であるのが好ましい。
The axial part 3 should just be equipped with the thin-plate-like adhering piece part 3b in the base end part of the rod-shaped grip part 3a.
The shape of the fixed piece 3b is not particularly limited, but is preferably circular, semicircular, or elliptic when viewed in plan. Among these, a semicircular shape is preferable.

固着片部3bの大きさ、すなわち上面視した際の面積、言い換えれば軸部3の基端部を薬液塗布部2の上面に固着する際の固着面積は、薬液塗布部2の上面、すなわちスポンジ上面の面積の2〜90%を占めるように設計することが好ましい。
薬液塗布部2の上面全面に固着させると、溶融した樹脂がスポンジの内部空隙に入り込んでしまい、抱液可能量を低下させてしまう。他方、固着面積が小さい場合でも薬液塗布部2に軸部3を固定することは可能であるが、スポンジを薬液に含浸した際自重に耐え切れず、スポンジが垂れてしまう。
かかる観点から、薬液塗布部2の上面に軸部3を固着する面積は、薬液塗布部2の上面の面積の2〜90%とするのが好ましく、特に30〜85%、その中でも特に60〜75%とするのが好ましい。
The size of the fixing piece portion 3b, that is, the area when viewed from above, in other words, the fixing area when the base end portion of the shaft portion 3 is fixed to the upper surface of the chemical solution application portion 2, is the upper surface of the chemical solution application portion 2, that is, the sponge. It is preferable to design so as to occupy 2 to 90% of the area of the upper surface.
If it is fixed to the entire upper surface of the chemical solution application part 2, the melted resin enters the internal space of the sponge and reduces the amount of liquid that can be held. On the other hand, even when the fixing area is small, the shaft portion 3 can be fixed to the chemical solution application part 2, but when the sponge is impregnated with the chemical solution, it cannot withstand its own weight and the sponge hangs down.
From this point of view, the area where the shaft portion 3 is fixed to the upper surface of the chemical solution application part 2 is preferably 2 to 90% of the area of the upper surface of the chemical solution application part 2, particularly 30 to 85%, and particularly preferably 60 to 60%. It is preferably 75%.

薬液塗布部2に軸部3を固定する手段は、接着剤によって固着するのではなく、軸部を構成する樹脂を溶融させるなどして、軸部を構成する樹脂の一部をスポンジの内部空隙、すなわちスポンジの空隙孔内に侵入させて冷却固化させて物理的に係合させることにより固着することが重要である。
具体的には、例えばインサート成形(アウトサート成形を含む)や熱融着のように固着するのが好ましい。
接着剤によって薬液塗布部2に軸部3を固着すると、長期保存しているうちに接着剤が薬液に溶解して汚染する可能性があるばかりか、経時的に接着力が低下するため長期保存していると剥がれてしまうおそれがある。これに対して、インサート成形(アウトサート成形を含む)や熱融着の場合には、軸部3を形成する樹脂が薬液塗布部2のスポンジの空隙孔内に侵入して物理的に係合するため、接着破壊を生じることもないし、固着力が経時的に低下することもなく、しかも薬液を汚染する心配もない。
より具体的には、インサート品としての薬液塗布部2を金型内に装填し固定し、軸部3を形成する溶融樹脂を、該薬液塗布部2の上面に射出するようにして軸部3を成形すると共に薬液塗布部2と固着するようにすればよい。
なお、インサート成形する場合には、固着片部3bの外周縁部を、薬液塗布部2の上面の外周縁部より内側に配置する。言い換えれば、固着片部3bの外周縁部と薬液塗布部2の上面の外周縁部との間に距離を置くように配置するのが好ましい。インサート成形する場合、固着片部3bの外周縁部と薬液塗布部2の上面の外周縁部と重ねて面一に配置すると、軸部3を構成する樹脂が薬液塗布部2の側面にまで回り込むことが判明した。
The means for fixing the shaft portion 3 to the chemical solution application portion 2 is not fixed by an adhesive, but melts the resin constituting the shaft portion, so that a part of the resin constituting the shaft portion is made into an internal space of the sponge. That is, it is important to fix by making it penetrate into the pores of the sponge, solidify by cooling and physically engage.
Specifically, for example, it is preferably fixed like insert molding (including outsert molding) or heat fusion.
When the shaft part 3 is fixed to the chemical solution application part 2 with an adhesive, the adhesive may dissolve in the chemical solution and become contaminated during long-term storage. There is a risk of peeling off. On the other hand, in the case of insert molding (including outsert molding) or thermal fusion, the resin forming the shaft portion 3 penetrates into the pores of the sponge of the chemical solution application portion 2 and is physically engaged. Therefore, there is no adhesion failure, the fixing force does not decrease with time, and there is no fear of contaminating the chemical solution.
More specifically, the chemical liquid application part 2 as an insert product is loaded and fixed in a mold, and the molten resin forming the shaft part 3 is injected onto the upper surface of the chemical liquid application part 2 so as to be injected. And is fixed to the chemical solution application unit 2.
In the case of insert molding, the outer peripheral edge portion of the fixing piece portion 3 b is disposed inside the outer peripheral edge portion of the upper surface of the chemical solution application portion 2. In other words, it is preferable to dispose a distance between the outer peripheral edge of the fixing piece 3b and the outer peripheral edge of the upper surface of the chemical solution application section 2. In the case of insert molding, if the outer peripheral edge portion of the fixed piece 3b and the outer peripheral edge portion of the upper surface of the chemical solution application portion 2 are arranged to be flush with each other, the resin constituting the shaft portion 3 wraps around the side surface of the chemical solution application portion 2. It has been found.

(収容容器4)
収容容器4は、例えば薬液塗布部2を収容する薬液塗布部収容凹部5と、軸部3を収容する軸部収容凹部4aとを有し、これら薬液塗布部収容凹部5及び軸部3をとり囲むようにシール鍔部4eを備える構成に形成することができる。
(Container 4)
The storage container 4 includes, for example, a chemical solution application portion storage recess 5 that stores the chemical solution application portion 2 and a shaft portion storage recess 4a that stores the shaft portion 3. It can form in the structure provided with the seal collar part 4e so that it may surround.

収容容器4の材質は、特に限定するものではないが、保形性、耐薬品性、薬液の浸透及び揮発を抑えるバリア性などを備えた樹脂からなるシート乃至フィルムから形成されているものが好ましい。例えば、ポリスチレン、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレートなどを好ましく用いることができる。   The material of the container 4 is not particularly limited, but is preferably formed from a sheet or film made of a resin having shape retention, chemical resistance, barrier properties for suppressing chemical penetration and volatilization, and the like. . For example, polystyrene, polyethylene, polypropylene, polyethylene terephthalate and the like can be preferably used.

薬液塗布部収容凹部5は、薬液塗布部2を隙間なくすっぽりと収容することができるように、その平面視形状を、薬液塗布部2の平面視形状に沿って一回り大きく形成するのが好ましい。図1の例では、扁平板状の薬液塗布部2に沿って浅底の凹部として形成してある。
この際、一回り大きくとは、薬液塗布部2は薬液を吸収すると横方向に若干、すなわち全体の15〜25%程度横方向に膨張するため、薬液を供給する前の乾燥状態の平面視幅の15〜25%に加えて若干の余裕(0.5mm〜5mm)を加えて大きい平面視幅に形成するのが好ましい。
他方、薬液塗布部収容凹部5の深さは、薬液塗布部2が薬液を吸収して厚さ方向に復元膨張した際の厚さに若干の余裕(0.5mm〜5mm)を加えた長さの深さに形成するのが好ましい。
It is preferable that the chemical liquid application part accommodating recess 5 is formed to have a larger size in plan view along the planar view shape of the chemical liquid application part 2 so that the chemical liquid application part 2 can be completely accommodated without gaps. . In the example of FIG. 1, a shallow concave portion is formed along the flat plate-shaped chemical solution application portion 2.
At this time, “larger” means that when the chemical solution application part 2 absorbs the chemical solution, it slightly expands in the lateral direction, that is, about 15 to 25% of the whole in the lateral direction. In addition to 15 to 25%, a slight margin (0.5 mm to 5 mm) is preferably added to form a large planar view width.
On the other hand, the depth of the concave portion 5 containing the chemical solution application portion is a length obtained by adding a slight margin (0.5 mm to 5 mm) to the thickness when the chemical solution application portion 2 absorbs the chemical solution and expands and restores in the thickness direction. Preferably, it is formed to a depth of.

軸部収容凹部4aは、薬液塗布部収容凹部5と連通し、且つ軸部3を完全に収容できるように形成すればよい。例えば軸部3の平面視形状に沿って細長い溝状の平面視形状に形成してもよいし、また、薬液塗布部収容凹部5とは反対側寄り部位に幅広部を設けておき、軸部3を指で掴み易くするようにしてもよい。   The shaft housing recess 4a may be formed so as to communicate with the chemical solution coating housing housing recess 5 and to completely store the shaft 3. For example, it may be formed in an elongated groove-like planar view shape along the planar view shape of the shaft portion 3, and a wide portion is provided at a portion on the opposite side to the chemical solution application portion receiving recessed portion 5, and the shaft portion You may make it easy to grasp 3 with a finger.

シール鍔部4eは、シート蓋体を重ねてシールするための部分であり、適宜幅をもって形成するのが好ましい。   The seal collar 4e is a portion for sealing the sheet lid body in an overlapping manner, and is preferably formed with an appropriate width.

(薬液)
収容する薬液の種類は特に制限するものではない。例えばポビドンヨード液、アルコール、過酸化水素などの消毒用薬液、ローション、ベビーオイルなどの化粧液、その他液状の薬液、蒸留水などを挙げることができる。中でも、OH基を有するセルロースを主成分とするスポンジとのなじみ易さの観点から、水溶液からなる薬液(例えばポビドンヨード液)が特に好ましい。
(Medical solution)
The type of chemical solution to be stored is not particularly limited. For example, povidone iodine solution, antiseptic chemicals such as alcohol and hydrogen peroxide, cosmetics such as lotion and baby oil, other liquid chemicals, and distilled water can be used. Among these, a chemical solution (for example, povidone iodine solution) composed of an aqueous solution is particularly preferable from the viewpoint of easy compatibility with a sponge mainly composed of cellulose having an OH group.

薬液は、薬液塗布部2と共に薬液塗布部収容凹部5内に収容するものであるが、本発明においては、薬液塗布部収容凹部5内に収容する量が重要である。すなわち、薬液塗布部収容凹部5内に、薬液塗布部2と共に薬液塗布部2の抱液可能量と同量、具体的な数値で言えば、抱液可能量の15〜95質量%量の薬液を収容することが重要である。
薬液塗布部2の抱液可能量と同量、すなわち抱液可能量の15〜95質量%量の薬液を収容することで、患部に必要十分な量の薬液を塗布することができるばかりか、余分な薬液が薬液塗布部収容凹部内に存在しないから、薬液が滴り落ちたり、使用後に余分な薬液が過剰に残ったり、製造時にシール部分に薬液が付着して密閉性を妨げるようなことを無くすことができる。
かかる観点から、薬液塗布部収容凹部5内に収容する薬液の量は、薬液塗布部2の抱液可能量の15〜95質量%量が好ましく、特に20〜90質量%量、中でも特に50〜70質量%量であるのがさらに好ましい。
The chemical solution is to be accommodated in the chemical solution application part accommodating recess 5 together with the chemical solution application part 2, but in the present invention, the amount to be accommodated in the chemical solution application part accommodating recess 5 is important. That is, in the chemical solution application part receiving recess 5, the amount of the liquid solution that can be held in the chemical solution application unit 2 together with the chemical solution application unit 2, that is, in a specific numerical value, 15 to 95% by mass of the liquid solution possible amount. It is important to accommodate.
By storing the same amount of the lysable amount of the medicinal solution application part 2, that is, 15 to 95% by mass of the lysable amount, it is possible to apply a necessary and sufficient amount of medicinal solution to the affected part, Since there is no excess chemical in the recess where the chemical solution is applied, the chemical may drip, excessive excess chemical may remain after use, or the chemical may adhere to the seal part during manufacturing and prevent sealing. It can be lost.
From this point of view, the amount of the chemical liquid stored in the chemical liquid application part receiving recess 5 is preferably 15 to 95% by mass, particularly 20 to 90% by mass, especially 50 to 50% by mass of the liquid application part 2 capable of lysing. More preferably, the amount is 70% by mass.

薬液塗布部収容凹部5内に収容する薬液の量は、患部の種類や大きさ、或いは薬液塗布部収容凹部5の大きさなどにより適宜変更するのが好ましいから、それに合わせて薬液塗布部2の大きさ・収容する薬液の量を調整するのが好ましい。   The amount of the chemical solution stored in the chemical solution application portion receiving recess 5 is preferably changed as appropriate depending on the type and size of the affected part, the size of the drug solution application portion storage recess 5, and the like. It is preferable to adjust the size and the amount of the chemical solution to be contained.

(シート蓋体)
シート蓋体は、その材質を特に限定するものではないが、防水性、耐薬品性を備えている必要がある。例えば、樹脂基材シートのシート面に金属薄膜層を積層してなる複合シートを好ましい一例として挙げることができ、具体的には、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレートなどの樹脂基材シートに、アルミ等の金属を蒸着乃至ラミネートして金属薄膜層を積層してなる複合シートなどを好ましく用いることができる。
(Seat lid)
The material of the seat lid is not particularly limited, but it needs to be waterproof and chemical resistant. For example, a composite sheet formed by laminating a metal thin film layer on the sheet surface of a resin base sheet can be cited as a preferred example. Specifically, a resin base sheet such as polyethylene, polypropylene, polyethylene terephthalate, aluminum, etc. A composite sheet obtained by depositing or laminating a metal and laminating a metal thin film layer can be preferably used.

(製造方法)
本薬液塗布用キットの製造方法については、特に制限するものではない。例えば、薬液塗布部収容凹部5内に薬液塗布部2を挿入すると共に、軸部収容凹部4a内に軸部3を挿入するようにして収容容器4内に薬液塗布具1を挿入した後、薬液を薬液塗布部2に注いで供給し、次いで薬液塗布部収容凹部5及び軸部収容凹部4aを被覆するようにシート蓋体を被覆シールするようにして薬液塗布用キットを製造するのが好ましい。
(Production method)
The method for producing the drug solution coating kit is not particularly limited. For example, after inserting the chemical solution application part 2 into the chemical solution application part accommodating recess 5 and inserting the chemical solution applicator 1 into the receiving container 4 so as to insert the shaft part 3 into the shaft part accommodating recess 4a, Is preferably poured into the chemical solution application section 2 and then the chemical solution application kit is manufactured by covering and sealing the sheet lid so as to cover the chemical solution application section receiving recess 5 and the shaft portion receiving recess 4a.

薬液よりも先に薬液塗布具1を収容容器4内に収容し、その後、薬液塗布部収容凹部5内の薬液塗布部2に薬液を供給することにより、薬液を薬液塗布部2が吸収するから薬液を零すことなく供給することができる。
この際、薬液塗布部2に対して、当該薬液塗布部2の抱液可能量と同量の薬液、すなわち抱液可能量の15〜95質量%量の薬液を、薬液塗布部収容凹部5内の薬液塗布部2に供給することにより、シール鍔部4e等に薬液が飛び散るのを防ぐことができ、シート蓋体を密閉状態に被覆シールすることができる。
Since the chemical solution applicator 1 is accommodated in the container 4 prior to the chemical solution, and then the chemical solution is supplied to the chemical solution application unit 2 in the chemical solution application unit receiving recess 5, the chemical solution application unit 2 absorbs the chemical solution. The chemical can be supplied without spilling.
At this time, with respect to the chemical solution application unit 2, the same amount of the chemical solution as the lysable amount of the chemical solution application unit 2, that is, 15 to 95% by mass of the lysable amount is stored in the chemical solution application unit housing recess 5. By supplying to the chemical solution application part 2, it is possible to prevent the chemical liquid from splashing on the seal collar 4 e and the like, and the sheet lid can be covered and sealed in a sealed state.

かかる製造方法においては、前述したように、圧縮前に比べて厚さが1/4〜1/10となるように厚さ方向にのみ圧縮成形されたスポンジ、言い換えれば、薬液を吸収すると圧縮された分だけ厚さ方向に膨張して復元するスポンジから薬液塗布部2を形成するのが好ましい。
圧縮前に比べて厚さが1/4〜1/10となるように厚さ方向にのみ圧縮成形されたスポンジを使用することにより、吸液速度を高めることができると共に、薬液を吸収した際に厚さ方向に復元膨張し、しかも吸収後の形状が安定しているから、薬液塗布部収容凹部5の平面視形状を、薬液塗布部2の平面視形状に沿って若干大きく形成すればよく、しかも安定した状態に薬液塗布部2を収容することができる。
かかる観点から、薬液塗布部2は、圧縮前に比べて厚さが1/4〜1/10、中でも特に1/5〜1/10となるように厚さ方向にのみ圧縮成形されたスポンジであるのがより一層好ましい。
In such a manufacturing method, as described above, a sponge that is compression-molded only in the thickness direction so as to have a thickness of ¼ to 1/10 of that before compression, in other words, compressed when absorbing a chemical solution. It is preferable to form the chemical solution application part 2 from a sponge that expands and restores in the thickness direction.
By using a sponge that is compression-molded only in the thickness direction so that the thickness is 1/4 to 1/10 compared to before compression, the liquid absorption speed can be increased and the chemical liquid is absorbed. Therefore, the shape in plan view of the chemical solution application portion receiving recess 5 may be slightly larger along the shape in plan view of the chemical solution application portion 2. And the chemical | medical solution application part 2 can be accommodated in the stable state.
From this point of view, the chemical solution application part 2 is a sponge that is compression-molded only in the thickness direction so that the thickness is 1/4 to 1/10, particularly 1/5 to 1/10, compared to before compression. Even more preferably.

また、同じく前述したように、薬液、特に10w/v%ポビドンヨード液の吸液速度が0.03〜0.5s/g、特に0.04〜0.5s/gであるスポンジからなる薬液塗布部2を使用するのが好ましい。
吸液速度が0.03〜0.5s/gであるスポンジであれば、薬液塗布部収容凹部5内の薬液塗布部2に薬液を注ぐと、薬液塗布部2が瞬時のうちに全体が濡れて薬液を吸収するため、薬液を薬液塗布部2に注いだ際に薬液が飛散することがないばかりか、薬液の供給からシート蓋体をシールするまでの時間が短くて済み、一連の工程を一つの生産ラインで実施することができ、本薬液塗布用キットの生産をオンラインで行うことができる。
Similarly, as described above, the chemical solution application part comprising a sponge having a liquid absorption rate of 0.03 to 0.5 s / g, particularly 0.04 to 0.5 s / g, of the chemical solution, particularly 10 w / v% povidone iodine solution. 2 is preferably used.
If the sponge has a liquid absorption speed of 0.03 to 0.5 s / g, when the chemical solution is poured into the chemical solution application portion 2 in the chemical solution application portion receiving recess 5, the chemical solution application portion 2 is instantly wetted. In order to absorb the chemical solution, when the chemical solution is poured into the chemical application unit 2, the chemical solution does not scatter, and the time from the supply of the chemical solution to the sealing of the seat lid can be shortened. It can be carried out in one production line, and the production of the drug solution application kit can be performed online.

(使用方法)
本薬液塗布用キットは、シート蓋体を収容容器4から剥がした後、図2に示すように、収容容器4から薬液塗布具1を取り出して薬液塗布具1の薬液塗布部2を患部に当てて移動させれば、薬液塗布部2に含浸した薬液を患部に塗布することができ、過剰な薬液が薬液塗布部収容凹部5内に収容されていないため、薬液が滴り落ちたり、使用後に余分な薬液が過剰に残ったり、薬液による軸汚れによって手が汚れたりすることがない。
その際、上記のようなスポンジからなる薬液塗布部2であれば、薬液を含浸させた状態で柔軟性があるので、患部にソフトな塗り心地で薬液を塗布することができる。さらに、セルローススポンジ2を患部に乗せただけで、押圧しなくても薬液が浸み出すから、薬液を患部に均一かつ十分に塗布することができる。
(how to use)
In this chemical solution application kit, after the sheet lid is peeled off from the storage container 4, as shown in FIG. 2, the chemical solution application tool 1 is taken out from the storage container 4, and the chemical solution application part 2 of the chemical solution application tool 1 is applied to the affected part. The chemical solution impregnated in the chemical solution application part 2 can be applied to the affected part, and the excessive chemical solution is not accommodated in the chemical solution application part accommodating recess 5, so that the chemical solution may drip or become extra after use. Therefore, there is no excess chemical solution remaining, and the hand is not soiled by shaft contamination by the chemical solution.
At that time, the chemical solution application part 2 made of a sponge as described above is flexible in a state of being impregnated with the chemical solution, so that the chemical solution can be applied to the affected area with a soft coating comfort. Furthermore, since the chemical liquid oozes out without being pressed by simply placing the cellulose sponge 2 on the affected area, the chemical liquid can be uniformly and sufficiently applied to the affected area.

(他の実施形態)
薬液塗布部収容凹部5及び軸部3を収容する軸部収容凹部4aのほかに、仕切りを設けると共に、ピンセット、ガーゼ、包帯、止血テープなどの医療器具を収容する医療器具収容凹部を設け、医療器具収容凹部内に医療器具を収容して、医療用キットとして形成することもできる。
(Other embodiments)
In addition to the medical solution application portion receiving recess 5 and the shaft portion receiving recess 4a for storing the shaft portion 3, a partition is provided, and a medical device receiving recess for receiving medical devices such as tweezers, gauze, bandages, hemostatic tape is provided. A medical instrument can be accommodated in the instrument accommodating recess to form a medical kit.

(用語の説明)
本発明において「セルローススポンジ」とは、セルロースを主成分とするスポンジの意味である。
本発明において「主成分」とは、特に記載しない限り、当該主成分の機能を妨げない範囲で他の成分を含有することを許容する意を包含する。この際、当該主成分の含有割合を特定するものではないが、主成分(2成分以上が主成分である場合には、これらの合計量)が組成物中の50質量%以上、特に70質量%以上、中でも特に90質量%以上(100%含む)を占めるのが好ましい。
(Explanation of terms)
In the present invention, “cellulose sponge” means a sponge mainly composed of cellulose.
In the present invention, the “main component” includes the meaning of allowing other components to be contained within a range that does not interfere with the function of the main component, unless otherwise specified. At this time, the content ratio of the main component is not specified, but the main component (when two or more components are main components, the total amount thereof) is 50% by mass or more, particularly 70% by mass in the composition. %, More preferably 90% by mass or more (including 100%).

本明細書において、「X〜Y」(X,Yは任意の数字)と表現した場合、特にことわらない限り「X以上Y以下」の意と共に、「好ましくはXより大きい」及び「好ましくはYより小さい」の意を包含する。
また、「X以上」(Xは任意の数字)或いは「Y以下」(Yは任意の数字)と表現した場合、「Xより大きいことが好ましい」或いは「Y未満であるのが好ましい」旨の意図も包含する。
In the present specification, when expressed as “X to Y” (X and Y are arbitrary numbers), unless otherwise stated, “preferably greater than X” and “preferably greater than or equal to X” "Less than Y" is included.
In addition, when expressed as “X or more” (X is an arbitrary number) or “Y or less” (Y is an arbitrary number), it is “preferably greater than X” or “preferably less than Y”. Includes intentions.

以下、各種試験及び実施例に基づいて本発明を説明するが、本発明が下記実施例に限定されるものではない。   Hereinafter, although this invention is demonstrated based on various tests and an Example, this invention is not limited to the following Example.

<薬液塗布部の材料選択試験>
薬液塗布部の材料を選択するために、異なる材料からなる下記検体について下記試験を行い、各検体の物性を比較し、薬液塗布部の材料について検討した。
た。
<Material selection test for chemical application part>
In order to select the material for the chemical solution application part, the following test was performed on the following specimens made of different materials, the physical properties of each specimen were compared, and the material for the chemical solution application part was examined.
It was.

(検体)
検体A:OH基を有するセルロースを主成分とし、セルロース100重量部に対して補強繊維としての綿繊維を30重量部含有する圧縮スポンジ(圧縮率1/5、空隙率98%、空隙の平均径0.8mm、タテ50.1mm×ヨコ50.6mm×高さ0.8mm、体積2,114mm3
検体B:市販の綿球(20番、タテ24.0mm×ヨコ21.7mm×高さ19.7mm)
検体C:市販の綿棒(5インチ綿棒 小)
(Sample)
Specimen A: Compressed sponge containing cellulose having OH group as a main component and 30 parts by weight of cotton fibers as reinforcing fibers with respect to 100 parts by weight of cellulose (compression rate 1/5, porosity 98%, average diameter of voids) 0.8mm, length 50.1mm x width 50.6mm x height 0.8mm, volume 2,114mm 3 )
Specimen B: Commercially available cotton ball (No. 20, vertical 24.0 mm × width 21.7 mm × height 19.7 mm)
Specimen C: Commercially available cotton swab (5 inch cotton swab small)

スポンジAは、木材パルプを水酸化ナトリウム溶液に浸漬し、圧搾後に粉砕してアルカリセルロース(クラム)とし、その後17℃で10時間老成後、二硫化炭素を加えセルロースザンテートを得、このセルロースザンテートに繊維長0.1〜5mmの未老成のクラムと水酸化ナトリウム、水を加えて溶解し、ビスコースを得、得られたビスコースと平均粒径0.8mmの芒硝結晶を混合機の中で16〜20℃に保ちながら混合し、途中で水を添加し混合物を馴染ませた。この混合物を金型に押出機を介して加圧充填した。その際、押出機周辺の温度も16〜20℃になるように温度調節した。混合物が充填された金型を約90℃の芒硝浴の中で約8時間煮沸し凝固させ、そして得られた成形体を水洗、乾燥、さらには厚み方向に、厚さが1/5となるように加圧して圧縮成型することによって得た圧縮スポンジを所定の大きさにカットしたものを用いた。   Sponge A is obtained by immersing wood pulp in a sodium hydroxide solution and crushing it to obtain alkali cellulose (crumb), then aging at 17 ° C. for 10 hours, and then adding carbon disulfide to obtain cellulose xanthate. Add undissolved crumb with 0.1-5 mm fiber length, sodium hydroxide and water to the tate to obtain viscose, and mix the resulting viscose with mirabilite crystals with an average particle size of 0.8 mm The mixture was kept while maintaining the temperature at 16 to 20 ° C., and water was added to adjust the mixture. This mixture was press-filled into a mold through an extruder. At that time, the temperature around the extruder was adjusted to 16 to 20 ° C. The mold filled with the mixture is boiled for about 8 hours in an about 90 ° C. mirabilite bath and solidified, and the resulting molded body is washed with water, dried, and the thickness becomes 1/5 in the thickness direction. A compression sponge obtained by pressurizing and compression-molding was cut into a predetermined size.

(抱液可能量の測定)
ステンレス製パッド内に検体全体が十分に浸かる量の10w/v%ポビドンヨード液を注ぎ、検体全体をポビドンヨード液内に浸して5分間浸漬させた後、金属メッシュ上に置いて検体から液滴を取り除いた上で、吸液時の単位体積重量を測定した。
予め、乾燥状態の検体の重量を測定しておき、下記式(2)より、単位体積当たりの抱液可能量を算出した。
(2)・・単位体積当たりの抱液可能量=吸液時の単位体積重量−乾燥時の単位体積重量
(Measurement of possible amount of liquid)
Pour 10w / v% povidone iodine solution in an amount sufficient to immerse the entire specimen in a stainless steel pad, immerse the entire specimen in povidone iodine solution and immerse for 5 minutes, then place it on a metal mesh to remove the droplets from the specimen. In addition, the unit volume weight at the time of liquid absorption was measured.
The weight of the sample in a dry state was measured in advance, and the amount of liquid that could be held per unit volume was calculated from the following formula (2).
(2) ··· Amount of liquid held per unit volume = Unit volume weight at the time of liquid absorption-Unit volume weight at the time of drying

(放液率の測定)
上記の如く、吸液時の単位体積重量を測定し後、検体に200gの加重を掛けて30秒放置した後に検体の重量(:放液後の単位体積重量)を測定し、式(3)より放液率を算出した。
(3)・・放液率=(吸液時の単位体積重量−放液後の単位体積重量)×100/(吸液時の単位体積重量−乾燥時の単位体積重量)
なお、消毒作業を実施する場合、200g以下の荷重で消毒箇所に薬液塗布具を押し当てられていると考えられるため、200gの荷重で放液率を測定した。
(Measurement of liquid discharge rate)
As described above, after measuring the unit volume weight at the time of liquid absorption, a weight of 200 g is applied to the sample and left for 30 seconds, and then the weight of the sample (: unit volume weight after liquid discharge) is measured, and the formula (3) The liquid release rate was calculated.
(3) .. Release rate = (unit volume weight upon liquid absorption−unit volume weight after liquid discharge) × 100 / (unit volume weight upon liquid absorption−unit volume weight upon drying)
In addition, when performing disinfection work, since it is thought that the chemical | medical solution application tool was pressed against the disinfection location with the load of 200 g or less, the liquid discharge rate was measured with the load of 200 g.

(吸液速度)
ステンレス製パッド内に10w/v%ポビドンヨード液を注ぎ、次いで検体(スポンジの直方体)をステンレス製パッド内に置いて下部をポビドンヨード液に浸し、検体(スポンジ)をステンレス製パッド内に置いてから検体の上面部まで吸液するまでの時間を測定し、次の式(4)より算出した。
(4)・・吸液速度=測定値(sec)/検体の吸液前の重量(g)
(Liquid absorption speed)
Pour 10 w / v% povidone iodine solution into a stainless steel pad, then place the specimen (sponge rectangular parallelepiped) in the stainless steel pad, immerse the lower part in the povidone iodine liquid, place the specimen (sponge) in the stainless steel pad, and then the specimen. The time until the liquid was absorbed up to the upper surface was measured and calculated from the following equation (4).
(4) .. Liquid absorption speed = measured value (sec) / weight of sample before liquid absorption (g)

(圧縮率)
検体を含水後、液垂れしない程度に軽く水を絞った状態として、圧縮率を測定した。
圧縮率の測定は、圧縮弾性試験機を用いて測定サンプルに50g/cm2の荷重をかけた時の厚み(T0:初期荷重厚み、mm)を測定した後、200g/cm2の荷重をかけた時の厚み(T1:初期荷重厚み、mm)を測定し、次の式(5)から圧縮率(%)を算出した。
(5)・・圧縮率=(T0−T1)×100/T0
表1には、n=3の平均値を示した。
(Compression rate)
After the specimen was hydrated, the compressibility was measured in a state where water was squeezed lightly enough to prevent dripping.
The compression rate was measured by measuring the thickness (T0: initial load thickness, mm) when a load of 50 g / cm 2 was applied to the measurement sample using a compression elasticity tester, and then applying a load of 200 g / cm 2. The thickness (T1: initial load thickness, mm) was measured, and the compression rate (%) was calculated from the following equation (5).
(5) .. Compression rate = (T0−T1) × 100 / T0
Table 1 shows the average value of n = 3.

Figure 0005833289
Figure 0005833289

検体Aの抱液可能量及び吸液速度は検体Bに比べて極めて大きく、検体Aは多量の薬液を吸収し保持できることが分かった。
また、検体Aの放液率及び圧縮率は検体Cに比べて極めて大きく、検体Aは吸収保持した薬液の多くを放出させることができ、しかも圧縮率が検体C(綿棒)に比べて高いことから、柔らかくて肌に優しいことが分かった。
The amount of the sample A that can be hydrated and the liquid absorption speed were extremely large compared to the sample B, and it was found that the sample A can absorb and retain a large amount of the drug solution.
In addition, the liquid discharge rate and the compression rate of the sample A are extremely larger than those of the sample C, and the sample A can release most of the absorbed and retained chemical solution, and the compression rate is higher than that of the sample C (cotton swab). I found that it was soft and gentle to the skin.

(薬液塗布試験)
ステンレス製パッド内に各検体を置き、10w/v%ポビドンヨード液2000mLを、に注いで薬液を吸収させた後、すぐに肌の上に載せて移動させて、塗布状態を比較検討した。その結果、検体Aは、薬液を瞬時に吸収し、注いだ薬液を全て吸収したが、検体Bは、薬液を全ては吸収できなかった。
また、検体Aは、薬液を吸収した状態で肌の上に載せて移動させただけで薬液を均等に塗布することができ、薬液が垂れるようなことがなかったが、他の検体は、最初に多くの薬液が浸み出して薬液が垂れてしまい、均等に塗布することはできなかった。
(Chemical solution application test)
Each specimen was placed in a stainless steel pad, and 2000 mL of 10 w / v% povidone iodine solution was poured into it to absorb the drug solution, and then immediately placed on the skin and moved to compare the application state. As a result, Sample A absorbed the chemical solution instantaneously and absorbed all the poured chemical solution, but Sample B could not absorb all the chemical solution.
In addition, the sample A can be applied evenly by simply moving it on the skin while absorbing the chemical solution, and the chemical solution did not sag. A large amount of the chemical solution oozes out and dripped down, and it was not possible to apply the solution evenly.

<固着試験>
薬液塗布部に対する軸部の固着手段並びに固着面積を種種変更して、好ましい固着手段を検討した。
<Fixing test>
Various types of fixing means and fixing area of the shaft portion with respect to the chemical solution application portion were changed, and preferred fixing means were examined.

(各種接着剤による固着)
検体Aのスポンジを使用し、厚さ5mm、半径30mmのスポンジ2枚を貼り合わせ、扁平な円板状(上面の面積706.5mm2)の薬液塗布部2を形成した。
他方、図3に示すように、ポリプロピレンからなり、その軸端部に、楕円薄板状(面積100.48mm2)の固着片部3bを形成するようにして軸部3を形成した。
そして、軸部3の固着片部3bの裏面に、ポリビニルアルコール系接着剤、エチレンビニルアルコール系接着剤、アクリル系接着剤、オレフィン系ホットメルト接着剤、合成ゴム系ホットメルト接着剤の何れかを塗布して、図4に示すように、軸部3の固着片部3bを薬液塗布部2の上面に固着した。
その後、10w/v%ポビドンヨード液に含浸し、アルミニウムを含む多層フィルムで密閉し、40℃、湿度75%環境下で2週間・1か月保存した後、島津社製引張試験機によって引張強度を測定した。
(Adhesion with various adhesives)
Using the sponge of specimen A, two sponges having a thickness of 5 mm and a radius of 30 mm were bonded together to form a flat disc-shaped (upper surface area 706.5 mm 2 ) chemical solution application part 2.
On the other hand, as shown in FIG. 3, the shaft portion 3 was formed by forming a fixed piece portion 3 b made of polypropylene and having an elliptical thin plate shape (area: 100.48 mm 2 ) at the shaft end portion.
Then, on the back surface of the fixed piece 3b of the shaft 3, any one of a polyvinyl alcohol adhesive, an ethylene vinyl alcohol adhesive, an acrylic adhesive, an olefin hot melt adhesive, and a synthetic rubber hot melt adhesive is applied. As shown in FIG. 4, the fixed piece 3 b of the shaft portion 3 was fixed to the upper surface of the chemical solution applying portion 2.
After that, impregnated with 10 w / v% povidone iodine solution, sealed with a multilayer film containing aluminum, stored for 2 weeks and 1 month in an environment of 40 ° C. and humidity 75%, and then tensile strength was measured by a Shimadzu tensile tester. It was measured.

ポリビニルアルコール系接着剤及びアクリル系接着剤は、2週間後の引張強度が極めて低いという結果を得た。
エチレンビニルアルコール系接着剤は、2週間後の引張強度は良好であったが、液状であるため、薬液塗布部2のスポンジ内に浸透してしまい、厚さ方向に復元しながら薬液を吸収する能力(復元力)が低下して薬液の抱液量が低下するという問題があることが分かった。
オレフィン系ホットメルト接着剤及び合成ゴム系ホットメルト接着剤は、1か月保存すると、接着力が低下して引張強度が低下することが判明した。
ただし、全ての接着剤において、軸部と検体Aのスポンジを直接接着させた場合、凝集破壊若しくは接着破壊が起こっており、接着剤による接着には問題があると考えられた。
Polyvinyl alcohol adhesives and acrylic adhesives obtained extremely low tensile strength after 2 weeks.
The ethylene vinyl alcohol adhesive had good tensile strength after 2 weeks, but because it was liquid, it penetrated into the sponge of the chemical application part 2 and absorbed the chemical while restoring in the thickness direction. It has been found that there is a problem in that the ability (restoring power) is reduced and the amount of liquid held in the chemical solution is reduced.
It has been found that when the olefin-based hot melt adhesive and the synthetic rubber-based hot melt adhesive are stored for one month, the adhesive strength decreases and the tensile strength decreases.
However, in all the adhesives, when the shaft portion and the sponge of the specimen A were directly bonded, cohesive failure or adhesive failure occurred, and it was considered that there was a problem in bonding with the adhesive.

(インサート成形による固着)
検体Aのスポンジ、すなわちセルローススポンジを使用し、圧縮後の厚さ1mm(圧縮前の厚さ5、7、10mm)、半径20mmの扁平な円板状(上面の面積314mm2)の薬液塗布部2を形成した。
この薬液塗布部2を金型内にセットし、薬液塗布部2の上面にポリプロピレンの溶融樹脂を射出させるようにして軸部3を形成すると共に薬液塗布部2の上面に固着した。この際、軸部3は、図4に示すように、その軸端部に楕円薄板状の固着片部3bを形成するようにしたが、この固着片部3bの面積を0〜100%の範囲で変更した。
上記試験同様に、10w/v%ポビドンヨード液に含浸し、アルミニウムを含む多層フィルムで密閉し、40℃、湿度75%環境下で2週間・1か月保存した後、島津社製引張試験機によって引張強度を測定した。また、上記同様に抱液可能量を測定し、その際、スポンジの様子を観察した。
(Fixed by insert molding)
Sample A sponge, that is, cellulose sponge, is a flat disk-shaped (upper surface area 314 mm 2 ) with a thickness of 1 mm after compression (thickness 5, 7, 10 mm before compression) and a radius of 20 mm. 2 was formed.
The chemical solution application part 2 was set in a mold, and a shaft portion 3 was formed so as to inject a molten polypropylene resin onto the upper surface of the chemical solution application part 2 and fixed to the upper surface of the chemical solution application part 2. At this time, as shown in FIG. 4, the shaft portion 3 is formed with an elliptical thin plate-like fixing piece portion 3b at the end portion of the shaft. The area of the fixing piece portion 3b is in the range of 0 to 100%. Changed in.
Similar to the above test, impregnated with 10 w / v% povidone iodine solution, sealed with a multilayer film containing aluminum, stored for 2 weeks and 1 month in an environment of 40 ° C. and 75% humidity, and then using a Shimadzu tensile tester. Tensile strength was measured. In addition, the amount of liquid that could be hydrated was measured in the same manner as described above, and the appearance of the sponge was observed.

なお、スポンジの垂れの様子を次の基準で評価し、表2に示した。
○:問題なし。
△:少し垂れている。
×:激しく垂れている
−:接着していない。
The state of the sponge hanging was evaluated according to the following criteria and shown in Table 2.
○: No problem.
Δ: Slightly drooping.
×: Dripping vigorously −: Not adhered.

Figure 0005833289
Figure 0005833289

このようにインサート成形すると、接着剤のように経時的に固着力が低下することがなく、長期保存しても薬液塗布部2に軸部3をしっかりと固着できることが判明した。この場合、検体Aのスポンジが破壊される基材破壊が起こっており、接着力は十分であることが考えることができた。
また、薬液塗布部2を剥がし、軸部3の接着面表面を観察したところ、凹凸ができていることが確認された。この凹凸は溶融樹脂がスポンジ内の空隙(孔)に入り込んで物理的に係合して固着しているものと考えることができる。
It has been found that when the insert molding is performed in this manner, the fixing force does not decrease with time unlike an adhesive, and the shaft portion 3 can be firmly fixed to the chemical solution application portion 2 even if stored for a long time. In this case, it was considered that the base material destruction in which the sponge of the specimen A was broken occurred and the adhesive force was sufficient.
Moreover, when the chemical | medical solution application part 2 was peeled and the adhesion surface surface of the axial part 3 was observed, it was confirmed that the unevenness | corrugation was made. This unevenness can be considered that the molten resin enters the void (hole) in the sponge and is physically engaged and fixed.

このことより固着力の問題は解決したが、薬液塗布部2が薬液を吸収して厚さ方向に復元する際の復元力(言い換えれば抱液力)が低下する場合があることが判明した。
これについては、着片部3bの大きさ、すなわち固着面積を小さくすることによって解決できることが分かった。よって、抱液力を維持するためには、薬液塗布部2の上面の固着面積を90%以下にするのが好ましく、特に85%以下、中でも特に75%以下にするのが好ましいことが分かった。
他方、薬液塗布部2の上面の固着面積を2%以上(幅1mm以上)にすると、固着力を維持することができ、30%以上(幅4mm以上)にすると、薬液塗布部2が薬液を吸収した際の自重によって薬液塗布部2が激しく垂れないようにすることができ、60%以下(幅12mm以下)にすると少しも垂れてないようにすることができることも判明した。
よって、固着片部3bの大きさ、すなわち薬液塗布部2に対する軸部3の固着面積は、薬液塗布部2の上面の2〜90%であるのが好ましく、特に30〜85%、中でも特に60〜75%であるのが好ましいことが分かった。
This has solved the problem of the sticking force, but it has been found that the restoring force (in other words, the liquid holding force) when the chemical solution application unit 2 absorbs the chemical solution and restores it in the thickness direction may decrease.
It has been found that this can be solved by reducing the size of the piece 3b, that is, the fixing area. Therefore, in order to maintain the liquid holding power, it was found that the fixing area of the upper surface of the chemical solution application part 2 is preferably 90% or less, particularly 85% or less, and particularly preferably 75% or less. .
On the other hand, when the fixing area of the upper surface of the chemical solution application part 2 is 2% or more (width 1 mm or more), the fixing force can be maintained, and when it is 30% or more (width 4 mm or more), the chemical solution application part 2 removes the chemical solution. It has also been found that the chemical application part 2 can be prevented from dripping drastically due to its own weight when absorbed, and it can be prevented from dripping at all when it is 60% or less (width 12 mm or less).
Therefore, the size of the fixed piece 3b, that is, the fixed area of the shaft portion 3 with respect to the chemical solution application part 2 is preferably 2 to 90% of the upper surface of the chemical solution application part 2, particularly 30 to 85%, especially 60. It has been found that it is preferably ˜75%.

(実施例)
上記のようにインサート成形によって軸部3を形成し、固着片部3bの面積を50%として、上記検体Aのスポンジからなる薬液塗布部2と軸部3とを一体化させて薬液塗布具1を形成した。このときの抱液可能量は平均で約1.8g(最大約2.1g〜最小約1.6g)、回収可能量は約80%となる。
そして、薬液塗布部収容凹部5に薬液塗布部2を挿入すると共に軸部収容凹部4aに軸部3を挿入するようにして収容容器4内に薬液塗布具1を収容した後、前記薬液塗布部2内の薬液塗布部2に対して上方から、薬液塗布部2に0.103〜2.06(0.103、0.206、0.309、0.412、0.515、1.03、1.133、1.236、1.339、1.442、1.545、1.648、1.751、1.854、1.957、2.06)gの薬液を注ぎ、次いで薬液塗布部収容凹部5及び軸部収容凹部4aを被覆するようにシート蓋体を被覆シールして薬液塗布用キットを製造した。
(Example)
As described above, the shaft part 3 is formed by insert molding, the area of the fixed piece part 3b is 50%, and the chemical solution application part 2 made of the sponge of the specimen A and the shaft part 3 are integrated to form the chemical solution applicator 1. Formed. At this time, the amount capable of immersing is about 1.8 g (maximum about 2.1 g to minimum about 1.6 g), and the recoverable amount is about 80%.
Then, after the chemical solution application part 2 is inserted into the chemical solution application part receiving recess 5 and the shaft part 3 is inserted into the shaft part storage recess 4a, the chemical solution applicator 1 is stored in the storage container 4, and then the chemical solution application part 2 to 0.13 to 2.06 (0.103, 0.206, 0.309, 0.412, 0.515, 1.03, from above to the chemical solution application unit 2 in 1.133, 1.236, 1.339, 1.442, 1.545, 1.648, 1.751, 1.854, 1.957, 2.06) g of chemical liquid is poured, and then the chemical liquid application section The sheet lid was covered and sealed so as to cover the housing recess 5 and the shaft housing recess 4a, to produce a chemical solution coating kit.

Figure 0005833289
Figure 0005833289

この結果、薬液塗布部収容凹部5内に収納する薬液の量、すなわち薬液塗布部2に注ぐ薬液の量は、患部に必要十分な量の薬液を塗布することができる点、薬液塗布部収容凹部5から薬液塗布部2を取り出した際に薬液が滴り落ちる点、使用後に余分な薬液が残る点、製造時にシール部分に薬液が付着する点などから、薬液塗布部2の抱液可能量の15〜95質量%量とするのが好ましく、特に20〜90質量%量、中でも特に50〜70質量%量であるのが好ましいことが分かった。   As a result, the amount of the chemical liquid stored in the chemical liquid application part receiving recess 5, that is, the amount of the chemical liquid poured into the chemical liquid application part 2 can apply a necessary and sufficient amount of chemical liquid to the affected part, From the point that the chemical solution dripped when the chemical solution application unit 2 is taken out from 5, the extra chemical solution remaining after use, the point that the chemical solution adheres to the seal part at the time of manufacture, etc. It was found that the amount was preferably -95% by mass, particularly 20-90% by mass, and particularly preferably 50-70% by mass.

1 薬液塗布具
2 薬液塗布部
3 軸部
3a 掴み部
3b 固着片部
4 収容容器
4a 軸部収容凹部
4e シール鍔部
5 薬液塗布部収容凹部
DESCRIPTION OF SYMBOLS 1 Chemical solution applicator 2 Chemical solution application part 3 Shaft part 3a Grasp part 3b Adhering piece part 4 Storage container 4a Shaft part accommodation recessed part 4e Seal collar part 5 Chemical solution application part accommodation recessed part

Claims (3)

セルローススポンジからなる板状の薬液塗布部と、該薬液塗布部の上面に固着される固着片部及び掴み部を有する樹脂製の軸部と、を備えた薬液塗布具であって、
薬液塗布具の製造過程において、軸部を構成する樹脂が溶融し、この溶融樹脂が、薬液塗布部を構成するスポンジ内の空隙に入り込んで係合した状態の固定手段により、薬液塗布部の上面と軸部の固着片部の下面部とが固着してなる構成を備えた薬液塗布具。
A chemical solution applicator comprising a plate-shaped chemical solution application portion made of cellulose sponge, and a resin shaft portion having a fixing piece portion and a grip portion fixed to the upper surface of the chemical solution application portion,
In the manufacturing process of the chemical solution applicator, the upper surface of the chemical solution application portion is fixed by fixing means in which the resin constituting the shaft portion is melted and the molten resin enters and engages the gap in the sponge constituting the chemical solution application portion. And a chemical solution applicator having a configuration in which the lower surface portion of the fixing piece portion of the shaft portion is fixed.
軸部の固着片部は、薬液塗布部の上面の面積の40〜90%を被覆することを特徴とする請求項1に記載の薬液塗布具。   The chemical solution applicator according to claim 1, wherein the fixing piece portion of the shaft portion covers 40 to 90% of the area of the upper surface of the chemical solution application portion. 請求項1又は2に記載の薬液塗布具と、
前記薬液塗布部を収容する薬液塗布部収容凹部、及びこの薬液塗布部収容凹部と連通した、軸部を収容する軸部収容凹部を有する収容容器と、
薬液塗布部収容凹部及び軸部収容凹部を被覆し得るシート蓋体と、を備えた薬液塗布用キットであって、
薬液塗布部収容凹部内に、薬液塗布部と共に当該薬液塗布部の抱液可能量の15〜95質量%量の薬液を収容し、軸部収容凹部内に軸部を収容し、前記薬液塗布部収容凹部及び軸部収容凹部をシート蓋体で密閉してなる構成を備えた薬液塗布用キット。
The chemical solution applicator according to claim 1 or 2 ,
A container containing a chemical liquid application part accommodating recess for accommodating the chemical liquid application part, and a shaft part accommodating concave part communicating with the chemical liquid application part accommodating concave part for accommodating a shaft part;
A chemical liquid application kit comprising: a sheet lid that can cover the chemical liquid application portion accommodating recess and the shaft portion accommodating recess;
In the chemical liquid application part housing recess, together with the chemical liquid application part, 15 to 95% by mass of the liquid storable amount of the chemical liquid application part is accommodated, the shaft part is accommodated in the shaft part accommodating recess, and the chemical liquid application part A chemical solution coating kit having a configuration in which a housing recess and a shaft housing recess are sealed with a sheet lid.
JP2010018074A 2010-01-29 2010-01-29 Chemical solution applicator and chemical solution application kit Active JP5833289B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010018074A JP5833289B2 (en) 2010-01-29 2010-01-29 Chemical solution applicator and chemical solution application kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010018074A JP5833289B2 (en) 2010-01-29 2010-01-29 Chemical solution applicator and chemical solution application kit

Publications (2)

Publication Number Publication Date
JP2011156024A JP2011156024A (en) 2011-08-18
JP5833289B2 true JP5833289B2 (en) 2015-12-16

Family

ID=44588565

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010018074A Active JP5833289B2 (en) 2010-01-29 2010-01-29 Chemical solution applicator and chemical solution application kit

Country Status (1)

Country Link
JP (1) JP5833289B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014094135A (en) * 2012-11-09 2014-05-22 Agurisu:Kk Solution applicator

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3976195A (en) * 1974-04-18 1976-08-24 Modern Medical Concepts, Inc. Sealed package of swab or applicator stick and medicinal material to be applied thereby
US5288159A (en) * 1992-12-04 1994-02-22 Minnesota Mining And Manufacturing Company Liquid applicator with frangible ampoule and support
JP2007077320A (en) * 2005-09-15 2007-03-29 Toray Fine Chemicals Co Ltd Cellulose sponge and method for producing cellulose sponge product or commodity
JP4680969B2 (en) * 2007-09-14 2011-05-11 株式会社ホギメディカル Medical chemical liquid applicator and its handle

Also Published As

Publication number Publication date
JP2011156024A (en) 2011-08-18

Similar Documents

Publication Publication Date Title
CA2163123C (en) Controlled oxygen/anti-microbial release films
RU2496523C2 (en) Clean-out instrument
JP2013545605A (en) Cleaning tool
JP4230278B2 (en) Package and fluid adhesion method
JP5833289B2 (en) Chemical solution applicator and chemical solution application kit
JP4944070B2 (en) Chemical solution application kit
WO2011087124A1 (en) Makeup tip
JP6600181B2 (en) Applicator with chemicals
JP4157878B2 (en) Lip treatment patch
JP2010029597A (en) Method of manufacturing medicinal solution application kit
JP2009028392A (en) Cosmetic puff
JP2014094135A (en) Solution applicator
EP0847264A1 (en) Selectively sorbent article and method for use in dental applications
US20070264316A1 (en) Patch Activated In Use
JP5909908B2 (en) Liquid applicator
JP2015223345A (en) Chemical solution application tool
CN211409702U (en) Puncture patch loaded with compound lidocaine emulsifiable paste
EP1483011A1 (en) Pre-moistened applicators for chemical reactant delivery
JP5739142B2 (en) Wet seat container
US20240032670A1 (en) Patch for bringing a cosmetic composition into contact with the skin
JP2013006402A (en) Cloth-like sheet material which can be freely made to be in wet state and method for producing the same
JP2003321342A (en) Pack sheet
JP2006062682A (en) Packaging body
JP4336012B2 (en) Immediate cooling type cooling package
KR102501178B1 (en) Versatile contactless applicator with reservoir

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20121031

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130830

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130903

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131024

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140401

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140613

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150608

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150903

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151029

R150 Certificate of patent or registration of utility model

Ref document number: 5833289

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250